PROMINENT and AD-RIDDLE, two projects focusing on Alzheimer’s disease, are channelling health economics to ensure that new therapies and diagnostic methods for Alzheimer’s disease can be effectively implemented.

Alzheimer Europe Is looking to immediately recruit a Communications Officer (m/f/x) to join its Communications team.

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither…

Welcome to the FluiDx-AD project! FluiDx-AD is a collaborative Horizon Europe-funded project aimed at improving Alzheimer’s disease diagnosis and management.…

On 19 February, at its plenary session in Berlin, the Gemeinsame Bundesausschuss (G-BA), Germany’s highest healthcare decision-making body representin

YouTube video by TEDx Talks

Cross Border Grants fördern internationale Alzheimer-Forschung mit bis zu 200.000 Euro. Neu: Auch weltweite Kooperationen sind förderfähig.

On 9 October 2025, the FluiDx-AD consortium held its General Assembly meeting in Bologna, Italy. The FluiDx-AD project, funded by the European Union’s Horizon Europe programme with a budget of EUR 7,6...

Background HemoDx, a Norwegian company, have developed a saliva collection device and kit to obtain and transport dried saliva samples cheaply and safely. The device consists of a special paper-based ...

Urgently disrupting the impact of childhood dementia. Childhood Dementia Initiative exists to find answers and better ways to research and treat the 70+ disorders that lead to childhood dementia. Thro...

When we talk about the great health challenges facing the UK, cancer and heart disease rightly come to mind. But too often we overlook dementia – the leading cause of death in this country for some ti...

In this spotlight on early-career researchers, Lena Sannemann from the University Hospital Cologne shares how Public Involvement (PI) is shaping the development…